WASHINGTON, Feb. 21, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on April 26, 2024 to holders of record on March 28, 2024.
ABOUT DANAHER Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
SugarCRM today announced its powerful AI-driven sales automation solution, Sugar Sell, has been named "Best New Product of the Year" in this year's Stevie American Business Awards.
The Stevie American Business Awards recognize top achievements in...
SmartRent, Inc. ("SmartRent" or the "Company"), a leading provider of smart home and property operations solutions for the rental housing industry, today reported financial results for the three months ended March 31, 2024. Management is hosting an...
Astria Therapeutics, Inc. , a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present information on the preclinical profile of STAR-0310 at the upcoming...
Booz Allen Hamilton today announced it was awarded a Blanket Purchase Agreement (BPA) by the U.S. Environmental Protection Agency (EPA) Office of Research and Development (ORD) to support the agency's modernization efforts and its mission to protect...
Skillsoft , a leading platform for transformative learning experiences, today announced that it has achieved Workday Certified Integration Status. Skillsoft, which is a Workday, Inc. software partner, now integrates with Workday Human Capital...
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Clay Siegall, PhD, President and Chief Executive Officer, will present at the 2024 Bank of America...
